221 related articles for article (PubMed ID: 31707784)
21. CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals.
Simrén J; Brum WS; Ashton NJ; Benedet AL; Karikari TK; Kvartsberg H; Sjons E; Lussier FZ; Chamoun M; Stevenson J; Hopewell R; Pallen V; Ye K; Pascoal TA; Zetterberg H; Rosa-Neto P; Blennow K
Alzheimers Res Ther; 2022 Dec; 14(1):192. PubMed ID: 36544221
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.
de Almeida SM; Ribeiro CE; Rotta I; Piovesan M; Tang B; Vaida F; Raboni SM; Letendre S; Potter M; Batistela Fernandes MS; Ellis RJ;
J Neurovirol; 2018 Feb; 24(1):28-40. PubMed ID: 29063514
[TBL] [Abstract][Full Text] [Related]
23. Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.
Janelidze S; Pannee J; Mikulskis A; Chiao P; Zetterberg H; Blennow K; Hansson O
JAMA Neurol; 2017 Dec; 74(12):1492-1501. PubMed ID: 29114726
[TBL] [Abstract][Full Text] [Related]
24. Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.
Frankfort SV; Tulner LR; van Campen JP; Verbeek MM; Jansen RW; Beijnen JH
Curr Clin Pharmacol; 2008 May; 3(2):123-31. PubMed ID: 18700307
[TBL] [Abstract][Full Text] [Related]
25. Elevated Tau PET Signal Depends on Abnormal Amyloid Levels and Correlates with Cognitive Impairment in Elderly Persons without Dementia.
Zhang RQ; Chen SD; Shen XN; Yang YX; Lu JY; Cui M; Zuo CT; Dong Q; Tan L; Yu JT;
J Alzheimers Dis; 2020; 78(1):395-404. PubMed ID: 32986669
[TBL] [Abstract][Full Text] [Related]
26. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
[TBL] [Abstract][Full Text] [Related]
27. Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment.
Rolstad S; Berg AI; Bjerke M; Blennow K; Johansson B; Zetterberg H; Wallin A
J Alzheimers Dis; 2011; 26(1):135-42. PubMed ID: 21593572
[TBL] [Abstract][Full Text] [Related]
28. Dual-Task Performance and Neurodegeneration: Correlations Between Timed Up-and-Go Dual-Task Test Outcomes and Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
Åhman HB; Giedraitis V; Cedervall Y; Lennhed B; Berglund L; McKee K; Kilander L; Rosendahl E; Ingelsson M; Åberg AC
J Alzheimers Dis; 2019; 71(s1):S75-S83. PubMed ID: 31104024
[TBL] [Abstract][Full Text] [Related]
29. Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults.
Albrecht DS; Sagare A; Pachicano M; Sweeney MD; Toga A; Zlokovic B; Chui H; Joe E; Schneider L; Morris JC; Benzinger T; Pa J
Brain Behav Immun; 2021 May; 94():299-307. PubMed ID: 33486003
[TBL] [Abstract][Full Text] [Related]
30. Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients.
D'Anna L; Abu-Rumeileh S; Fabris M; Pistis C; Baldi A; Sanvilli N; Curcio F; Gigli GL; D'Anna S; Valente M
Neurodegener Dis; 2017; 17(4-5):227-234. PubMed ID: 28719891
[TBL] [Abstract][Full Text] [Related]
31. Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease.
Tzen KY; Yang SY; Chen TF; Cheng TW; Horng HE; Wen HP; Huang YY; Shiue CY; Chiu MJ
ACS Chem Neurosci; 2014 Sep; 5(9):830-6. PubMed ID: 25054847
[TBL] [Abstract][Full Text] [Related]
32. Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project.
Verberk IMW; Hendriksen HMA; van Harten AC; Wesselman LMP; Verfaillie SCJ; van den Bosch KA; Slot RER; Prins ND; Scheltens P; Teunissen CE; Van der Flier WM
Neurobiol Aging; 2020 May; 89():99-107. PubMed ID: 32081465
[TBL] [Abstract][Full Text] [Related]
33. P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders.
Ma LZ; Hu H; Wang ZT; Ou YN; Dong Q; Tan L; Yu JT
Alzheimers Res Ther; 2021 Dec; 13(1):200. PubMed ID: 34911582
[TBL] [Abstract][Full Text] [Related]
34. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
[TBL] [Abstract][Full Text] [Related]
35. Alteration in amyloid β42, phosphorylated tau protein, interleukin 6, and acetylcholine during diabetes-accelerated memory dysfunction in diabetic rats: correlation of amyloid β42 with changes in glucose metabolism.
Zhou Y; Zhao Y; Xie H; Wang Y; Liu L; Yan X
Behav Brain Funct; 2015 Aug; 11():24. PubMed ID: 26271247
[TBL] [Abstract][Full Text] [Related]
36. Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults.
Guo T; Landau SM; Jagust WJ;
Alzheimers Res Ther; 2021 Oct; 13(1):174. PubMed ID: 34654465
[TBL] [Abstract][Full Text] [Related]
37. Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia.
Gertje EC; Janelidze S; van Westen D; Cullen N; Stomrud E; Palmqvist S; Hansson O; Mattsson-Carlgren N
Neurology; 2023 Apr; 100(17):e1812-e1824. PubMed ID: 36882326
[TBL] [Abstract][Full Text] [Related]
38. Correlation between abnormal GSK3β, β Amyloid, total Tau, p-Tau 181 levels and neuropsychological assessment total scores in CKD patients with cognitive dysfunction: Impact of rHuEPO therapy.
Vinothkumar G; Krishnakumar S; Riya ; Venkataraman P
J Clin Neurosci; 2019 Nov; 69():38-42. PubMed ID: 31447360
[TBL] [Abstract][Full Text] [Related]
39. Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
Chong JR; Ashton NJ; Karikari TK; Tanaka T; Saridin FN; Reilhac A; Robins EG; Nai YH; Vrooman H; Hilal S; Zetterberg H; Blennow K; Lai MKP; Chen CP
Alzheimers Dement; 2021 Oct; 17(10):1649-1662. PubMed ID: 33792168
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.
Ashton NJ; Brum WS; Di Molfetta G; Benedet AL; Arslan B; Jonaitis E; Langhough RE; Cody K; Wilson R; Carlsson CM; Vanmechelen E; Montoliu-Gaya L; Lantero-Rodriguez J; Rahmouni N; Tissot C; Stevenson J; Servaes S; Therriault J; Pascoal T; Lleó A; Alcolea D; Fortea J; Rosa-Neto P; Johnson S; Jeromin A; Blennow K; Zetterberg H
JAMA Neurol; 2024 Mar; 81(3):255-263. PubMed ID: 38252443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
